(Logo: http://photos.prnewswire.com/prnh/20020822/XLNXLOGO)
The Xilinx Board of Directors announced a quarterly cash dividend of
Additional third quarter comparisons are represented in the charts below:
|
GAAP Results (In millions, except EPS) | ||||||
|
Growth Rates | ||||||
|
Q3 FY 2013 |
Q2 FY 2013 |
Q3 FY 2012 |
Q-T-Q |
Y-T-Y | ||
|
Net revenues |
|
|
|
-6% |
0% | |
|
Operating income |
|
|
|
-18% |
-12% | |
|
Net income |
|
|
|
-16% |
-18% | |
|
Diluted earnings per share |
|
|
|
-17% |
-19% | |
"New Product sales increased 17% sequentially in the December quarter, driven by robust adoption of Kintex™-7 and Virtex®-6 FPGAs. Strength from New Products is an encouraging sign in the face of macroeconomic conditions that remained challenging during the quarter," said
|
Net Revenues by Geography:
| ||||||
|
Percentages |
Growth Rates | |||||
|
Q3 FY 2013 |
Q2 FY 2013 |
Q3 FY 2012 |
Q-T-Q |
Y-T-Y | ||
|
|
32% |
28% |
32% |
6% |
0% | |
|
|
34% |
36% |
35% |
-11% |
-3% | |
|
|
24% |
26% |
23% |
-15% |
1% | |
|
|
10% |
10% |
10% |
-4% |
5% | |
|
Net Revenues by End Market:
| ||||||
|
Percentages |
Growth Rates | |||||
|
Q3 FY 2013 |
Q2 FY 2013 |
Q3 FY 2012 |
Q-T-Q |
Y-T-Y | ||
|
|
47% |
49% |
46% |
-11% |
2% | |
|
Industrial, Aerospace & Defense |
36% |
32% |
34% |
7% |
5% | |
|
Broadcast, Consumer & Automotive |
15% |
15% |
15% |
-7% |
-2% | |
|
Other |
2% |
4% |
5% |
-42% |
-52% | |
|
Net Revenues by Product:
| ||||||
|
Percentages |
Growth Rates | |||||
|
Q3 FY 2013 |
Q2 FY 2013 |
Q3 FY 2012 |
Q-T-Q |
Y-T-Y | ||
|
New |
25% |
20% |
14% |
17% |
79% | |
|
Mainstream |
41% |
47% |
43% |
-18% |
-4% | |
|
Base |
30% |
29% |
39% |
-3% |
-24% | |
|
Support |
4% |
4% |
4% |
1% |
3% | |
Products are classified as follows:
New products: Virtex‐7, Kintex‐7, Artix™-7, Zynq™-7000, Virtex‐6, Spartan™‐6 products
Mainstream products: Virtex‐5, Spartan‐3 and CoolRunner(TM)‐II products
Base products: Virtex‐4, Virtex‐II, Virtex‐E, Virtex, Spartan-II, Spartan, CoolRunner and XC9500 products
Support products: Configuration solutions, HardWire, Software & Support/Services
|
Key Statistics: (Dollars in millions)
| |||
|
Q3 FY 2013 |
Q2 FY 2013 |
Q3 FY 2012 | |
|
Annual Return on Equity (%)* |
17 |
19 |
22 |
|
Operating |
|
|
|
|
Depreciation Expense |
|
|
|
|
Capital Expenditures |
|
|
|
|
Combined Inventory Days |
131 |
109 |
142 |
|
Revenue Turns (%) |
57 |
57 |
56 |
|
*Return on equity calculation: Annualized net income/average stockholders' equity | |||
Highlights - December Quarter Fiscal 2013
Business Outlook — March Quarter Fiscal 2013
Conference Call
A conference call will be held today at
This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as "expect," "believe," "may," "will," "could," "anticipate," "estimate," "continue," "plan," "intend," "project" or other similar expressions. Statements that refer to or are based on projections, uncertain events or assumptions also identify forward-looking statements. Such forward looking statements include, but are not limited to, statements related to the semiconductor market, the growth and acceptance of our products, expected revenue growth, the demand and growth in the markets we serve, opportunity for expansion into new markets, and our expectations regarding our business outlook for the March quarter for fiscal 2013. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including customer acceptance of our new products, current global economic conditions, the health of our customers and the end markets in which they participate, our ability to forecast end customer demand, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, and other risk factors listed in our most recent Forms 10-Q and 10-K.
About
#1303
XLNX-F
Investor Relations Contact:
(408) 879-6911
ir@xilinx.com
|
| |||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
|
(Unaudited) | |||||||||
|
(In thousands, except per share amounts)
| |||||||||
|
Three Months Ended |
Nine Months Ended | ||||||||
|
|
|
|
December 29, 2012 |
December 31, 2011 | |||||
|
Net revenues |
$ 509,767 |
$ 543,933 |
$ 511,091 |
$ 1,636,484 |
$ 1,681,763 | ||||
|
Cost of revenues |
170,493 |
187,713 |
174,805 |
556,617 |
598,501 | ||||
|
Gross margin |
339,274 |
356,220 |
336,286 |
1,079,867 |
1,083,262 | ||||
|
Operating expenses: |
|||||||||
|
Research and development |
129,055 |
113,887 |
108,245 |
364,389 |
320,036 | ||||
|
Selling, general and administrative |
86,823 |
91,928 |
88,934 |
274,952 |
274,011 | ||||
|
Amortization of acquisition-related intangibles |
2,554 |
2,319 |
1,982 |
7,021 |
5,587 | ||||
|
Restructuring charges |
— |
— |
— |
— |
3,369 | ||||
|
Total operating expenses |
218,432 |
208,134 |
199,161 |
646,362 |
603,003 | ||||
|
Operating income |
120,842 |
148,086 |
137,125 |
433,505 |
480,259 | ||||
|
Interest and other expense, net |
5,149 |
10,003 |
7,187 |
24,824 |
23,596 | ||||
|
Income before income taxes |
115,693 |
138,083 |
129,938 |
408,681 |
456,663 | ||||
|
Provision for income taxes |
12,045 |
14,646 |
2,924 |
51,765 |
48,989 | ||||
|
Net income |
$ 103,648 |
$ 123,437 |
$ 127,014 |
$ 356,916 |
$ 407,674 | ||||
|
Net income per common share: |
|||||||||
|
Basic |
$ 0.40 |
$ 0.47 |
$ 0.49 |
$ 1.36 |
$ 1.54 | ||||
|
Diluted |
$ 0.38 |
$ 0.46 |
$ 0.47 |
$ 1.31 |
$ 1.50 | ||||
|
Cash dividends per common share |
$ 0.22 |
$ 0.22 |
$ 0.19 |
$ 0.66 |
$ 0.57 | ||||
|
Shares used in per share calculations: |
|||||||||
|
Basic |
260,690 |
260,605 |
261,257 |
261,723 |
264,183 | ||||
|
Diluted |
271,174 |
270,265 |
267,884 |
271,861 |
271,713 | ||||
|
| |||
|
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
|
(In thousands)
| |||
|
|
| ||
|
(unaudited) |
|||
|
ASSETS |
|||
|
Current assets: |
|||
|
Cash, cash equivalents and short-term investments |
$ 1,686,631 |
$ 1,917,627 | |
|
Accounts receivable, net |
232,257 |
214,965 | |
|
Inventories |
225,985 |
204,866 | |
|
Deferred tax assets and other current assets |
118,698 |
112,851 | |
|
Total current assets |
2,263,571 |
2,450,309 | |
|
Net property, plant and equipment |
373,369 |
394,982 | |
|
Long-term investments |
1,560,132 |
1,209,228 | |
|
Other assets |
415,835 |
409,603 | |
|
Total Assets |
$ 4,612,907 |
$ 4,464,122 | |
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||
|
Current liabilities: |
|||
|
Accounts payable and accrued liabilities |
$ 285,525 |
$ 275,774 | |
|
Deferred income on shipments to distributors |
50,017 |
67,002 | |
|
Total current liabilities |
335,542 |
342,776 | |
|
Convertible debentures |
918,883 |
906,569 | |
|
Deferred tax liabilities |
506,995 |
463,045 | |
|
Other long-term liabilities |
35,362 |
44,047 | |
|
Stockholders' equity |
2,816,125 |
2,707,685 | |
|
Total Liabilities and Stockholders' Equity |
$ 4,612,907 |
$ 4,464,122 | |
|
* Derived from audited financial statements | |||
|
SUPPLEMENTAL FINANCIAL INFORMATION | |||||||||
|
(Unaudited) | |||||||||
|
(In thousands)
| |||||||||
|
Three Months Ended |
Nine Months Ended | ||||||||
|
|
|
|
|
| |||||
|
SELECTED CASH FLOW INFORMATION: |
|||||||||
|
Depreciation |
$ 13,680 |
$ 14,151 |
$ 13,862 |
$ 42,434 |
$ 40,956 | ||||
|
Amortization |
4,423 |
4,188 |
4,327 |
12,878 |
12,363 | ||||
|
Stock-based compensation |
19,762 |
19,246 |
17,843 |
56,616 |
48,509 | ||||
|
Net cash provided by operating activities |
122,568 |
197,370 |
180,970 |
482,884 |
618,248 | ||||
|
Purchases of property, plant and equipment |
8,075 |
7,636 |
18,984 |
24,053 |
50,401 | ||||
|
Payment of dividends to stockholders |
57,326 |
57,255 |
49,566 |
172,647 |
150,370 | ||||
|
Repurchases of common stock |
19,602 |
87,441 |
42,447 |
197,750 |
219,638 | ||||
|
Proceeds from issuance of common stock to employees and excess tax benefit |
20,608 |
28,627 |
12,017 |
58,262 |
71,836 | ||||
|
STOCK-BASED COMPENSATION INCLUDED IN: |
|||||||||
|
Cost of revenues |
$ 1,517 |
$ 1,473 |
$ 1,350 |
$ 4,718 |
$ 3,944 | ||||
|
Research and development |
9,654 |
9,404 |
8,655 |
27,681 |
23,245 | ||||
|
Selling, general and administrative |
8,591 |
8,369 |
7,838 |
24,217 |
21,320 | ||||
SOURCE
News Provided by Acquire Media